Facility

Johnson & Johnson (NYSE:JNJ) is expanding in Wilson County, North Carolina, with a new multibillion-dollar pharmaceutical facility. The company expects to create up to 500 new jobs in the community through the project in Wilson. It marks the second time in 14 months that J&J has announced a significant project in the area after a…

Conveyors provide healthcare packaging operations with a critical function – seamlessly moving product from one station to the next. A function seemingly so simple, it’s at risk of being overlooked for proper analysis before implementation. But conveyors build the foundation of every successful packaging operation, and investing the time to analyze the varying options and…

The lessons learned in mastering autologous manufacturing—where precision, flexibility, and data integrity are pushed to their limits—are shaping how biopharma advances efficiency and control across every process. The innovations happening in the personalized medicine space are some of the most exciting life sciences advancements in the history of humankind. Many of the autologous, patient-specific therapies…

Sai Life Sciences has opened Unit VI, a purpose-built veterinary API facility in Bidar, Karnataka, adjacent to the company’s flagship Unit IV API site. According to the company, the new plant is configured for stringent EHS practices and regulatory readiness to supply animal-health APIs at commercial scale. The unit will support global animal-health customers with…

Johnson & Johnson (NYSE:JNJ) announced today that it plans to increase its biopharmaceutical manufacturing presence in North Carolina. The company committed $2 billion toward a 160,000+-square-foot dedicated manufacturing facility at Fujifilm’s new biopharmaceutical manufacturing site in Holly Springs, North Carolina. Its commitment spans the next 10 years, expanding its U.S. manufacturing capacity and creating approximately…

Bionova Scientific, a subsidiary of Asahi Kasei, today announced the opening of a new plasmid DNA (pDNA) production facility in The Woodlands, Texas. The 10,000-square-foot, state-of-the-art development and production facility sits less than 30 miles north of Houston. It designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. pDNA…

Thermo Fisher Scientific recently announced plans to acquire Sanofi’s sterile manufacturing site in Ridgefield, New Jersey, and continue producing a portfolio of Sanofi therapies there while opening the facility to additional pharmaceutical and biotech customers. The plant performs sterile fill-finish and packaging, and has more than 200 employees, all of whom will join Thermo Fisher…

Varda Space Industries recently announced a $187 million fundraise, bringing the total amount of money raised to $329 million for the El Segundo, California–based startup. Natural Capital and Shrug Capital led the Series C round, with participation from Founders Fund, Peter Thiel, Khosla Ventures, Caffeinated Capital, Lux Capital, and Also Capital. Varda Space Industries’ goal…

Hikma Pharmaceuticals USA recently announced that it will invest $1 billion by 2030 to further expand U.S. manufacturing and R&D. London-based Hikma has already invested more than $4 billion over the past 15 years in expanding its U.S. presence, which was first established in 1991. The new “America Leans on Hikma” phase, announced June 28,…

Great Point Partners has acquired a majority stake in Eutecma, a Germany-based developer of reusable and modular temperature-controlled packaging for pharmaceutical cold chain logistics. The investment will support Eutecma’s global expansion strategy, particularly in the U.S. market, and bolster its efforts to reduce emissions and waste in drug shipping and storage. Eutecma supplies passive cooling…